Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases

American Journal of Pathology

Volumn 153, Issue 3, 1998, Pages 681-687

  Thomas, George V ^a   Szigeti, Kinga ^a   Murphy, Michael ^a   Draetta, Giulio ^b   Pagano, Michele ^c   Loda, Massimo ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN P27; PROTEIN P53;

ADENOCARCINOMA; ADULT; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031689717     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65610-6     Document Type: Article

References (45)

1. Sherr CJ: Cancer cell cycles. Science 1996, 274:1672-1677
2. Cordon-Cardo C: Mutations of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 1995, 147:545-560
3. 1 restriction point. Crit Rev Oncog 1996, 7:127-142
4. 1-cyclin cdk protein kinase activity is related to p21. Cell 1994, 78:67-74
5. Polyak K, Lee MH, Erdjement-Bromage H, Koff A, Roberts JM, Tempst P, Massague J: Cloning of p27/kip1, a new cyclin kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994, 78:59-66
6. Pagano M, Beer-Romano P, Glass S, Tam SW, Theodoras A, Rolfe M, Draetta G: Targeting ubiquitin-mediated degradation for proliferation inhibitors. Cancer Genes. Edited by Milhich E, Housman D. New York, Plenum Publishing Corp, 1997, pp 255-268
7. kip1 accumulation during the cell cycle. Science 1996, 271:1861-1864
8. Sandhu C, Garbe J, Daksis J, Pan C-H, Bhattacharya N, Yaswen P, Koh J, Slingerland J, Stampfer MR: TGF-β stabilizes p15 INK4B protein increases p15 INK4B/cdk4 complexes, and inhibits cyclin D1/cdk4 association in human mammary epithelial cells. Mol Cell Biol 1997, 17:2458-2467
9. kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 1995, 55:1211-1214
10. Kawamata N, Morosetti R, Miller CW, Park D, Spirin K, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilczynski S, Lee Y, Bartram C, Koeffler H: Molecular analysis of the cyclin dependent kinase inhibitor p27/kip1 in human malignancies. Cancer Res 1995, 55:2266-2269
11. Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW, Koeffler H: p27/kip1 mutation found in breast cancer. Cancer Res 1996, 56:2400-2404
12. kip1 gene to 12p13 and its analysis in leukemias. Cancer Res 1995, 55:1206-1210
13. Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi-Galluzzi C, Pagano M, Loda M: The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a, b) invasive breast carcinomas. Cancer Res 1997, 57:1259-1263
14. kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997, 3:222-225
15. kip1 protein: prognostic implications in primary breast cancer. Nat Med 1997, 3:227-230
16. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M: Increased proteosome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997, 3:231-234
17. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K, Akiyoshi T: p27 expression and gastric carcinoma. Nat Med 1997, 3:593
18. Yang RM, Naitoh J, Philipson J, Wang H, deKernion JB, Loda M, Reiter RE: Low levels of p27 protein expression predict poor disease-free survival in patients with pathological T2a-T3b adenocarcinoma of the prostate. J Urol 1998, 159:941-945
19. kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 1998, 58:542-548
20. Singh SP, Lipman J, Goldman H, Ellis FH, Aizenman L, Cangi MG, Signoretti S, Chiaur DS, Pagano M, Loda M: Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res 1998, 58:1730-1735
21. Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M, Giordano A: Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 1997, 57:3381-3385
22. kip1 in human lung cancers: differential changes in small cell and non-small cell carcinomas. Cancer Res 1998, 58:1042-1047
23. Kastrinakis WV, Ramchurren N, Reiger KM, Hess DT, Loda M, Steele G, Summerhayes IC: Increased incidence of p53 mutations is associated with hepatic metastases in colorectal neoplastic progression. Oncogene 1995, 11:647-652
24. Bertorelle R, Esposito G, Del Mistro A, Belluco C, Nitti D, Lise M, Chieco-Bianchi L: Association of p53 gene and protein alterations with metastases in colorectal cancer. Am J Surg Pathol 1995, 19:463-471
25. Cady B, Stone M, McDermott WV, Jenkins RL, Bothe A, Lavin PT, Lovett EJ, Steele GD: Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 1992, 127:561-568
26. Ambiru S, Masaru M, Hiroshi I, Nakagawa K, Shimizu H, Kato A, Nakamura S, Omoto H, Nakajima N: Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer 1998, 82:274-278
27. Manual for staging of cancer: American Joint Committee on Cancer. Edited by Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. New York, J. B. Lippincott, 1992
28. kip1 deficient mice. Cell 1996, 85:733-744
29. kip1. Cell 1996, 85:721-732
30. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horri I, Loh D, Nakayama K: Mice lacking p27 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell 1996, 85:707-720
31. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiqitin-proteosome pathway in regulating abundance of cyclin-dependant kinase inhibitor p27. Science 1995, 269:682-685
32. Sahin AA, Ro JY, Brown RW, Ordonez NG, Cleary KR, El-Naggar AK, Wilson P, Ayala AG: Assessment of Ki-67 derived tumor proliferative activity in colorectal adenocarcinomas. Mod Pathol 1994, 7:17-21
33. Risio M, Coverlizza S, Ferrari A, Candelaresi G, Rossini S: Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas and adenocarcinomas of the large bowel. Gastroenterology 1988, 94:899-906
34. Ciaparrone M, Yamamoto H, Yao Y, Sgambato A, Cattoretti G, Tomita N, Monden T, Rotterdam H, Weinstein B: Localization and expression of p27 in multistage colorectal carcinogenesis. Cancer Res 1998, 58:114-122
35. Katayose Y, Kim M, Rakkar ANS, Li Z, Cowan KH, Seth P: Promoting apoptosis: A novel activity associated with the cyclin dependent kinase inhibitor p27. Cancer Res 1997, 57:5441-5445
36. Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science 1998, 280: 1069-1072
37. kip1 on adhesion-dependent resistance of tumor cells to anticancer agents. Nat Med 1996, 2:1204-1210
38. Polyak K, Kato M, Saloman MJ, Sherr CJ, Massague J, Roberts JM, Koff A: p27, a cyclin -cdk inhibitor, links TGF-β and contact inhibition to cell cycle arrest. Genes Dev 1994, 8:9-22
39. Schulze A, Zerfass-Thome J, Middendorp S, Jansen-Durr P, Henglein B: Anchorage-dependent transcription of the cyclin A gene. Mol Cell Biol 1996, 16:4632-4638
40. Zhu X, Ohtsubo M, Roberts J, Assosian R: Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2 and phosphorylation of the retinoblastoma protein. J Cell Biol 1996, 133:391-403
41. Fang F, Orend G, Watanabe N, Hunter T, Rouslathi E: Dependence of cyclin E-cdk2 kinase activity on cell anchorage. Science 1996, 271: 499-502
42. Arber N, Doki Y, Han EK, Sgambato A, Zhou P, Kim NH, Delohery T, Klein MG, Holt PR, Weinstein IB: Antisense to cyclin D1 inhibits the growth and tumorigenecity of human colon cancer cells. Cancer Res 1997, 57:1569-1574
43. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB, Holt PR: Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 1996, 110:669-674
44. Fearon ER, Volgelstein B: A genetic model for colorectal carcinogenesis. Cell 1990, 61:759-767
45. kip1 in anchorage-independent cells. Oncogene 1998, 16:2575-2583